Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional

A Study to Evaluate the Efficacy of Tolterodine on Specific Symptoms in Adult Patients With Overactive Bladder.

ClinicalTrials.gov ID: NCT00645281

Public ClinicalTrials.gov record NCT00645281. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 7:38 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Symptom Specific Effectiveness of Tolterodine ER 4 mg in Patients With Symptoms of Overactive Bladder (OAB) in a Primary Care Setting. A Phase IV, Open-label, Single-arm, Non-randomized, Trial in Adult Patients With OAB.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the efficacy and safety of tolterodine in impacting the primary symptom or complaint of patients with OAB.

Study identification

NCT ID
NCT00645281
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Enrollment
896 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2004 (Type not available)
Primary completion
Not listed
Completion
Jan 2005 (Actual)
Last update posted
Jan 27, 2021

2004 – 2005

United States locations

U.S. sites
96
U.S. states
27
U.S. cities
86
Facility City State ZIP Site status
Pfizer Investigational Site Birmingham Alabama 35211 —
Pfizer Investigational Site Birmingham Alabama 35213 —
Pfizer Investigational Site Birmingham Alabama 35234 —
Pfizer Investigational Site Huntsville Alabama 35801 —
Pfizer Investigational Site Montgomery Alabama 36117 —
Pfizer Investigational Site Phoenix Arizona 85051 —
Pfizer Investigational Site Sun Lakes Arizona 85248 —
Pfizer Investigational Site Bentonville Arkansas 72712 —
Pfizer Investigational Site Jonesboro Arkansas 72401 —
Pfizer Investigational Site Little Rock Arkansas 72204 —
Pfizer Investigational Site Buena Park California 90620 —
Pfizer Investigational Site Foothill Ranch California 92610 —
Pfizer Investigational Site Fresno California 93710 —
Pfizer Investigational Site West Covina California 91790 —
Pfizer Investigational Site Colorado Springs Colorado 80904 —
Pfizer Investigational Site Lakewood Colorado 80228 —
Pfizer Investigational Site Chipley Florida 32428 —
Pfizer Investigational Site Davie Florida 33328 —
Pfizer Investigational Site Hallandale Florida 33009 —
Pfizer Investigational Site Miami Florida 33145 —
Pfizer Investigational Site Miami Beach Florida 33140 —
Pfizer Investigational Site Murdock Florida 33948 —
Pfizer Investigational Site Ocala Florida 34471 —
Pfizer Investigational Site Pembroke Pines Florida 33024 —
Pfizer Investigational Site Saint Cloud Florida 34769 —
Pfizer Investigational Site Tampa Florida 33607 —
Pfizer Investigational Site Atlanta Georgia 30308 —
Pfizer Investigational Site Barnesville Georgia 30204 —
Pfizer Investigational Site Blue Ridge Georgia 30513 —
Pfizer Investigational Site Decatur Georgia 30034 —
Pfizer Investigational Site Chicago Illinois 60610 —
Pfizer Investigational Site Naperville Illinois 60564 —
Pfizer Investigational Site Orland Park Illinois 60462 —
Pfizer Investigational Site Newton Kansas 67114 —
Pfizer Investigational Site Shawnee Mission Kansas 66203 —
Pfizer Investigational Site Wichita Kansas 67205 —
Pfizer Investigational Site Wichita Kansas 67207 —
Pfizer Investigational Site Marrero Louisiana 70072 —
Pfizer Investigational Site Laurel Maryland 20707 —
Pfizer Investigational Site Oxon Hill Maryland 20745 —
Pfizer Investigational Site Jackson Michigan — —
Pfizer Investigational Site Portage Michigan 49002 —
Pfizer Investigational Site St Louis Missouri 63117 —
Pfizer Investigational Site Las Vegas Nevada 89128 —
Pfizer Investigational Site Las Vegas Nevada 89146 —
Pfizer Investigational Site Blackwood New Jersey 08012 —
Pfizer Investigational Site Mount Laurel New Jersey 08054 —
Pfizer Investigational Site Binghamton New York 13901 —
Pfizer Investigational Site Endicott New York 13760 —
Pfizer Investigational Site Endwell New York 13760 —
Pfizer Investigational Site Kingston New York 12401 —
Pfizer Investigational Site Beaufort North Carolina 28516 —
Pfizer Investigational Site Charlotte North Carolina 28207 —
Pfizer Investigational Site Charlotte North Carolina 28262 —
Pfizer Investigational Site Durham North Carolina 27703 —
Pfizer Investigational Site Morehead City North Carolina 28557 —
Pfizer Investigational Site Winston-Salem North Carolina 27103 —
Pfizer Investigational Site Columbus Ohio 43213 —
Pfizer Investigational Site Kettering Ohio 45429 —
Pfizer Investigational Site Central Point Oregon 97502 —
Pfizer Investigational Site Medford Oregon 97504 —
Pfizer Investigational Site Bala-Cynwyd Pennsylvania 19004 —
Pfizer Investigational Site Bensalem Pennsylvania 19020 —
Pfizer Investigational Site Connellsville Pennsylvania 15425 —
Pfizer Investigational Site Philadelphia Pennsylvania 19103 —
Pfizer Investigational Site Philadelphia Pennsylvania 19147 —
Pfizer Investigational Site Philadelphia Pennsylvania 19148 —
Pfizer Investigational Site Sellersville Pennsylvania 18960 —
Pfizer Investigational Site Stoneboro Pennsylvania 16153 —
Pfizer Investigational Site Warwick Rhode Island 02886 —
Pfizer Investigational Site Greer South Carolina 29651 —
Pfizer Investigational Site Simpsonville South Carolina 29681 —
Pfizer Investigational Site Cordova Tennessee 38018 —
Pfizer Investigational Site Huntingdon Tennessee 38344 —
Pfizer Investigational Site Lexington Tennessee 38351 —
Pfizer Investigational Site Savannah Tennessee 38372 —
Pfizer Investigational Site Selmer Tennessee 38375 —
Pfizer Investigational Site Waynesboro Tennessee 38485 —
Pfizer Investigational Site Austin Texas 78705 —
Pfizer Investigational Site Bryan Texas 77802 —
Pfizer Investigational Site Colleyville Texas 76034 —
Pfizer Investigational Site Friendswood Texas 77546 —
Pfizer Investigational Site Houston Texas 77030 —
Pfizer Investigational Site Plano Texas 75093-5841 —
Pfizer Investigational Site Plano Texas 75093 —
Pfizer Investigational Site San Antonio Texas 78217 —
Pfizer Investigational Site Salt Lake City Utah 84109 —
Pfizer Investigational Site Salt Lake City Utah 84121 —
Pfizer Investigational Site West Jordan Utah 84084 —
Pfizer Investigational Site West Valley City Utah 84120 —
Pfizer Investigational Site Spokane Washington 99207 —
Pfizer Investigational Site Spokane Washington 99208 —
Pfizer Investigational Site Milwaukee Wisconsin 53221 —
Pfizer Investigational Site New Berlin Wisconsin 53151 —
Pfizer Investigational Site Oregon Wisconsin 53575 —
Pfizer Investigational Site Wauwatosa Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00645281, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 27, 2021 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00645281 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →